Multidrug-resistant tuberculosis: Treatment outcome in Denmark, 1992–2007

References

• World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis, Emergency update 2008. WHO/HTM/TB/2008.402. Geneva: WHO; 2008.
   Google Scholar
• Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis 1998;2:10–5.
   PubMed Web of Science ®Google Scholar
• Chan ED, Iseman MD. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis 2008;21:587–95.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Anti-tuberculosis drug resistance in the world, Report No. 4. WHO/HTM/TB/2008.394. Geneva: WHO; 2008.
   Google Scholar
• Thomsen VO, Bauer J, Lillebaek T, Glismann S. Results from 8 yrs of susceptibility testing of clinical Mycobacterium tuberculosis isolates in Denmark. Eur Respir J 2000;16:203–8.
   PubMedGoogle Scholar
• Vijdea R, Stegger M, Sosnovskaja A, Andersen AB, Thomsen VO, Bang D. Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates. Eur J Clin Microbiol Infect Dis 2008;27:1079–86.
   PubMedGoogle Scholar
• Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, . Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005;9:640–5.
   PubMed Web of Science ®Google Scholar
• van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, . Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406–9.
   PubMed Web of Science ®Google Scholar
• Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, . Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997;35:907–14.
   PubMed Web of Science ®Google Scholar
• Chiang CY, Yew WW. Multidrug-resistant and extensively drug-resistant tuberculosis. Int J Tuberc Lung Dis 2009;13:304–11.
   PubMed Web of Science ®Google Scholar
• Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, . Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000;283:2537–45.
   PubMed Web of Science ®Google Scholar
• Geerligs WA, Van Altena R, De Lange WC, van Soolingen D, Van Der Werf TS. Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands. Int J Tuberc Lung Dis 2000;4:758–64.
   PubMed Web of Science ®Google Scholar
• Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993;328:527–32.
   PubMed Web of Science ®Google Scholar
• Chan ED, Laurel V, Strand MJ, Chan JF, Huynh ML, Goble M, . Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004;169:1103–9.
   PubMed Web of Science ®Google Scholar
• Avendano M, Goldstein RS. Multidrug-resistant tuberculosis: long term follow-up of 40 non-HIV-infected patients. Can Respir J 2000;7:383–9.
   PubMedGoogle Scholar
• Viskum K, Kok-Jensen A. Multidrug-resistant tuberculosis in Denmark 1993–1995. Int J Tuberc Lung Dis 1997;1:299–301.
   PubMedGoogle Scholar
• Turett GS, Telzak EE, Torian LV, Blum S, Alland D, Weisfuse I, . Improved outcomes for patients with multidrug-resistant tuberculosis. Clin Infect Dis 1995;21:1238–44.
   PubMed Web of Science ®Google Scholar
• Fortun J, Martin-Davila P, Molina A, Navas E, Hermida JM, Cobo J, . Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation? J Antimicrob Chemother 2007;59: 794–8.
   PubMedGoogle Scholar
• Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, . Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med 2006;144:650–9.
   PubMed Web of Science ®Google Scholar
• Mukherjee JS, Rich ML, Socci AR, Joseph JK, Viru FA, Shin SS, . Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004;363:474–81.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Policy guidance on drug-susceptibility testing of second-line antituberculous drugs. WHO/HTM/TB/2008.392. Geneva: WHO; 2008.
   Google Scholar
• Chan ED, Strand MJ, Iseman MD. Treatment outcomes in extensively resistant tuberculosis. N Engl J Med 2008;359:657–9.
   PubMed Web of Science ®Google Scholar